Evidence map›Paper›PMID 22778419›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2012

Eradication of bacterial persisters with antibiotic-generated hydroxyl radicals.

Sarah Schmidt Grant, Benjamin B Kaufmann, Nikhilesh S Chand, Nathan Haseley, Deborah T Hung

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 131 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
131citing papers in PubMed, 1 pooled it
8.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

131 citing papers in PubMed, 1 synthesis or guideline pooled it, 268 citations in OpenAlex.

  1. Systematic review of clofazimine for the treatment of drug-resistant tuberculosis.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2013
    Pooled it
  2. Trial
  3. Article
  4. Characterization of Antibiotic-Tolerant Persister Cells inAnimals : an open access journal from MDPI · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Usnic Acid Derivatives as Inhibitors ofInternational journal of molecular sciences · 2026
    Article
  11. Article
  12. Review
  13. Reactive Oxygen Detoxification Contributes tobioRxiv : the preprint server for biology · 2025
    Article
  14. Genetic determinants ofMicrobiology spectrum · 2025
    Article
  15. Phenolic constituents in pepper (Food chemistry: X · 2025
    Article
  16. Review
  17. Review
  18. Ferroptosis-Like Death Induction inJournal of microbiology and biotechnology · 2025
    Article
  19. Deciphering meropenem persistence inAntimicrobial agents and chemotherapy · 2025
    Article
  20. Article

71 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Sarah Schmidt GrantBroad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Benjamin B Kaufmann
Nikhilesh S Chand
Nathan Haseley
Deborah T Hung
Brigham and Women's Hospital · USHarvard–MIT Division of Health Sciences and Technology · USHarvard University · USMassachusetts General Hospital · US

Funding

Training Program in Bioinformatics and Integrative GenomicsT32HG002295 · NHGRI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Peter J Park · 2001 to 2026
$15.8M
Identifying essential functions in non replicating Mycobacterium tuberculosisK08AI085033 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI GRANT, SARAH S · 2010 to 2013
$549k
NHGRI NIH HHS T32 HG002295NIAID NIH HHS K08 AI085033
6 · The paper itself

Abstract

During Mycobacterium tuberculosis infection, a population of bacteria likely becomes refractory to antibiotic killing in the absence of genotypic resistance, making treatment challenging. We describe an in vitro model capable of yielding a phenotypically antibiotic-tolerant subpopulation of cells, often called persisters, within populations of Mycobacterium smegmatis and M. tuberculosis. We find that persisters are distinct from the larger antibiotic-susceptible population, as a small drop in dissolved oxygen (DO) saturation (20%) allows for their survival in the face of bactericidal antibiotics. In contrast, if high levels of DO are maintained, all cells succumb, sterilizing the culture. With increasing evidence that bactericidal antibiotics induce cell death through the production of reactive oxygen species (ROS), we hypothesized that the drop in DO decreases the concentration of ROS, thereby facilitating persister survival, and maintenance of high DO yields sufficient ROS to kill persisters. Consistent with this hypothesis, the hydroxyl-radical scavenger thiourea, when added to M. smegmatis cultures maintained at high DO levels, rescues the persister population. Conversely, the antibiotic clofazimine, which increases ROS via an NADH-dependent redox cycling pathway, successfully eradicates the persister population. Recent work suggests that environmentally induced antibiotic tolerance of bulk populations may result from enhanced antioxidant capabilities. We now show that the small persister subpopulation within a larger antibiotic-susceptible population also shows differential susceptibility to antibiotic-induced hydroxyl radicals. Furthermore, we show that stimulating ROS production can eradicate persisters, thus providing a potential strategy to managing persistent infections.

Indexed as

Anti-Bacterial AgentsClofazimineDrug Resistance, BacterialGreen Fluorescent ProteinsIn Vitro TechniquesMycobacterium smegmatisMycobacterium tuberculosisOxygenReactive Oxygen SpeciesThioureaTuberculosisAnti-Bacterial AgentsClofazimineGreen Fluorescent ProteinsOxygenReactive Oxygen SpeciesThiourea

Identifiers

PMID22778419
PMCPMC3409745
OpenAlexW2103584554

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.